• UV Treatment in the OR Environment
    Kim Horn, RN, BS, MPH, CIC, an infection control practitioner at Flagstaff Medical Center in Flagstaff, Ariz., conducted a two-week UV light treatment trial at her facility in January 2014. During the trial, zero surgical site infections were detected, which led to complete ...More
    Yesterday Posted in Whitepapers
  • Ebola Virus Disease: A Primer for Infection Preventionists
    This digital issue provides a summary of Ebola virus disease etiology, signs and symptoms, risk of exposure, transmission, and prevention strategies. It reviews the current outbreak situation, describes the public health response, and provides details regarding infection ...More
    Yesterday Posted in Digital Issues
  • FDA Approves First Vaccine to Prevent Serogroup B Meningococcal Disease
    The Food and Drug Administration (FDA) announced today the approval of Trumenba, the first vaccine licensed in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age. Meningococcal ...More
    Yesterday Posted in News
  • Epidemiological Study Investigates Parasite-Schizophrenia Connection
    Many factors, both genetic and environmental, have been blamed for increasing the risk of a diagnosis of schizophrenia. Some, such as a family history of schizophrenia, are widely accepted. Others, such as infection with Toxoplasma gondii, a parasite transmitted by soil, ...More
    Yesterday Posted in News
  • Genome of Enterovirus D68 Circulating in St. Louis is Sequenced
    Researchers at Washington University School of Medicine in St. Louis have sequenced the genome of enterovirus D68 sampled from patients treated at St. Louis Children’s Hospital. Nationwide, the virus has spread rapidly in recent months and caused severe respiratory ...More
    Yesterday Posted in News
  • WHO Welcomes Swissmedic Approval of Ebola Vaccine Trial at Lausanne University Hospital
    The World Health Organization (WHO) says it welcomes the approval by Swissmedic, the Swiss regulatory authority for therapeutic products, for a trial with an experimental Ebola vaccine at the Lausanne University Hospital. This marks the latest step toward bringing safe and ...More
    2 days ago Posted in News
  • UTHealth Research Shows Mushroom Extract Helpful in Treating HPV
    A Japanese mushroom extract appears to be effective for the eradication of human papillomavirus (HPV), according to a pilot clinical trial at the University of Texas Health Science Center at Houston (UTHealth) Medical School. The results were presented at the 11th ...More
    2 days ago Posted in News
  • Rutgers Expert Says Flu Virus More Threatening to Public Health Than Ebola
    With Americans on edge about the potential spread of Ebola, it is easy to overlook another virus to which we have long been accustomed – influenza. According to estimates by the Centers for Disease Control and Prevention (CDC), the flu takes anywhere from 3,000 to ...More
    2 days ago Posted in News
  • WHO Issues Interim Guidance on the Use of Delamanid in the Treatment of MDR-TB
    A new TB drug with a novel mechanism of action – delamanid - is now available for treatment of adults with multidrug-resistant tuberculosis (MDR-TB), a form of tuberculosis resistant to at least isoniazid and rifampicin, the main first-line drugs. Delamanid was ...More
    2 days ago Posted in News